Table 3 Expression levels and clinical pathological data analysis of RBM10 and SNHG17_2.

From: RBM10 suppresses colorectal cancer invasion by regulating LncRNA SNHG17 alternative splicing

Clinical pathological characteristics

RBM10 high expression

RBM10 low expression

p-value

SNHG17_2 high expression

SNHG17_2 low expression

p-value

(years)

      

> 60

19

11

0.0707

15

20

0.2949

≤ 60

11

19

 

15

10

 

Gender

      

Female

16

14

0.7963

15

15

1

Male

14

16

 

15

15

 

Tumor location

      

Right colon

12

8

0.7506

10

10

1

Left colon

10

10

 

10

10

 

Rectum

15

8

 

8

15

 

Tumor size

      

< 5 cm

25

5

0.00000093

10

20

0.0201

≥ 5 cm

5

25

 

20

10

 

Tumor invasion depth

      

T1

20

10

0.0242

6

5

0.0252

T2

6

14

 

6

10

 

T3

3

5

 

18

8

 

T4

1

1

 

2

7

 

Lymph node metastasis

      

Absent

20

10

0.0201

10

20

0.0201

Present

10

20

 

20

10

 

AJCC stage

      

I stage

20

10

0.0242

5

5

0.00894

II stage

6

14

 

20

10

 

III stage

3

5

 

3

10

 
Back to article page